The therapeutic efficacy of vildagliptin (DPP-4 inhibitor) in conventional solid dosage forms is limited by rapid systemic clearance and low intestinal permeability, resulting in frequent dosing and suboptimal glycemic control. This study aimed to address these limitations by developing vildagliptin-loaded liposomes enhanced with fenugreek (Trigonella foenumgraecum) to improve antidiabetic activity and sustain drug release through inhibition of GLP-1 and GIP degradation. Liposomes were prepared via the ether injection method and optimized using a full factorial design, with lecithin, cholesterol, and chitosan/PLGA as independent variables and drug entrapment efficiency and cumulative release as dependent responses. Characterization was performed using FTIR, SEM, zeta potential analysis, and in vitro release studies in a pH 1.2 buffer over 8 hours following the USP paddle method. Entrapment efficiency ranged from 87.99% to 92.52%, with the PLGA-based formulation (PLFE-4) showing the highest performance. SEM confirmed uniform, spherical vesicles averaging 93.5 nm in diameter. Release kinetics followed a zero-order model, indicating sustained drug release. Level A IVIVC modeling using ex vivo release data predicted that PLFE-4 exhibits reduced Cmax and delayed Tmax. In vivo studies in alloxan induced diabetic rats demonstrated sustained glycemic control for up to 8 hours and maintenance of HbA1c levels between 6% and 8%. These findings suggest that fenugreek-integrated vildagliptin liposomes represent a promising sustained-release platform for effective management of type II diabetes mellitus.
Sumaiya SH, Sharmin Mou SSM, Bahar NB, Ahmed SU, Islam S, Elias Al Mamun M, Dewan I. Investigation of the in vivo antidiabetic effects of vildagliptin–fenugreek loaded liposomes by preventing GLP-1 and GIP degradation. J Appl Pharm Sci. 2025. Article in Press. http://doi.org/10.7324/JAPS.2026.267587
1. Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et al. IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Dia Res Clin Pract. 2022;183:109119. doi: https://doi.org/10.1016/J.DIABRES.2021.109119
2. Lin T, Mayzel Y, Bahartan K. The accuracy of a non-invasive glucose monitoring device does not depend on clinical characteristics of people with type 2 diabetes mellitus. J Drug Ass. 2018;7(1):1–7. doi: https://doi.org/10.1080/21556660.JDA.2018.1423987
3. Dimer LM, Colonetti T, Rodrigues Uggioni ML, Dagostin Ferraz S, Grande AJ, Rosa MI, et al. Evaluation of the effects of Bauhinia forficata as an adjuvant in the treatment of type 2 diabetes mellitus: systematic review and meta-analysis. Eu J Inte Med. 2024;65:102331. doi: https://doi.org/10.1016/J.EUJIM.2024.102331
4. Chawla G, Pradhan T, Gupta O. An insight into the combat strategies for the treatment of type 2 diabetes mellitus. Mini Rev Med Chem. 2024;24(4):403–30. doi: https://doi.org/10.2174/MRMC.1389557523666230517113936
5. Satish B, Bikash LM, Tomal Z. Design and evaluation of sustained release microspheres. Int J Clin Prac. 2012;22:125–8.
6. Vyas SK, Roop V, Vyas S. Introduction of novel drug delivery systems. New Delhi, India: CBS Publishers & distribution; 2019.
7. Luo Y, Chen D, Ren L, Zhao X, Qin J. Solid lipid nanoparticles for enhancing vinpocetine’s oral bioavailability. J Ctrl Rel. 2006;114(1):53–9. doi: https://doi.org/10.1016/J.JCONREL.2006.05.010
8. Bhagwat RR, Vaidhya IS. Novel drug delivery systems: an overview. Int J Pharm Sci Res. 2013;4(3):970. doi: http://dx.doi.org/10.13040/IJPSR.0975-8232.4(3).970-82
9. Bernkop-Schnürch A, Guggi D, Pinter Y. Thiolated chitosans: development and in vitro evaluation of a mucoadhesive, permeation enhancing oral drug delivery system. J Ctrl Rel. 2004;94(1):177–86. doi: https://doi.org/10.1016/J.JCONREL.2003.10.005
10. Fatouros DG, Mullertz A. In vitro lipid digestion models in design of drug delivery systems for enhancing oral bioavailability. Exp Opin Drug Metab Toxicol. 2008;4(1):65–76. doi: https://doi.org/10.1517/EODMT.17425255.4.1.65
11. Bangham AD, Hill MW, Miller NGA. Preparation and use of liposomes as models of biological membranes. In: Korn ED, editor. Methods in membrane biology. New York, NY: Plenum Press; 1974, pp: 1–68.
12. Sur S, Fries AC, Kinzler KW, Zhou S, Vogelstein B. Remote loading of preencapsulated drugs into stealth liposomes. Proc NAS. 2014;111(6):2283–38. doi: https://doi.org/10.1073/PNAS.1324135111
13. Gao P, Guyton ME, Huang T, Bauer JM, Stefanski KJ, Lu Q. Enhanced oral bioavailability of a poorly water-soluble drug PNU91325 by super-saturatable formulations. Drug Dev Ind Pharm. 2004;30:221–9. doi: https://doi.org/10.1081/DDC-120028718
14. Abdelkader H, Ismail S, Kamal A, Alany RG. Design and evaluation of controlled-release niosomes and discomes for naltrexone hydrochloride ocular delivery. J Pharm Sci. 2011;100(5):1833–46. doi: https://doi.org/10.1002/JPS.22422
15. Naidu MM, Shyamala BN, Naik JP, Sulochanamma G, Srinivas P. Chemical composition and antioxidant activity of the husk and endosperm of fenugreek seeds. LWT-Food Sci Tech. 2011;44(2):451– 6. doi: https://doi.org/10.1016/J.LWT.2010.08.013
16. Mohima T, Dewan I, Islam SA, Rana S, Hossain AL. Encapsulation of zidovudine in different cellulosic acrylic and methacrylic polymers-loaded microspheres: in vitro characterization and compatibility studies. Int J Pharm Pharm Sci. 2015;7(1):486–95. doi: https://journals.innovareacademics.in/index.php/ijpps/article/view/4497
17. June CC, Lee HW, Sani HA, Latip J, Gansau JA, Lee PC, et al. Hypoglycemic effects of Gynura procumbens fractions on streptozotocin-induced diabetic rats involved phosphorylation of GSK3b (Ser-9) in liver. Sains Malaysiana. 2012;41:969–75.
18. Singh B, Kumar R, Ahuja N. Optimizing drug delivery systems using systematic design of experiments. Part I: fundamental aspects. Crit Rev Ther Drug Carr Syst. 2005;22(1): 27–105. doi: https://doi.org/10.1615/CritRevTherDrugCarrierSyst.v22.i1.20
19. Tiwari RK, Singh L, Singh MK. Design and statistical optimization of novel polyelectrolyte complex microbeads to improve entrapment efficiency and release study of vildagliptin. Rec Adv Drug Deliv Form. 2023;17(1):71–85. doi: https://doi.org/10.2174/RADDF.2667387817666230308113951
20. Dewan I, Islam S, Rana S. Characterization and compatibility studies of different rate retardant polymer loaded microspheres by solvent evaporation technique: in vitro-in vivo study of vildagliptin as a model drug. J Drug Deliv. 2015;2015:1–2. doi: https://doi.org/10.1155/JDD/2015/496807
21. Baig MMFA, Khan S, Naeem MA, Khan GJ, Ansari MT. Vildagliptin loaded triangular DNA nanospheres coated with eudragit for oral delivery and better glycemic control in type 2 diabetes mellitus. Bio & Pharm. 2018;97:1250–8. doi: https://doi.org/10.1016/J.BIOPHA.2017.11.059
22. Guo Y, Li X, Macgregor RB, Yan H, Zhang RX. Microfluidics-based PLGA nanoparticles of ratiometric multidrug: from encapsulation and release rates to cytotoxicity in human lens epithelial cells. Heliyon. 2023;9(7):e18318. doi: http://dx.doi.org/10.1016/j.heliyon.2023.e18318
23. Ryu S, Park S, Lee HY, Lee H, Cho CW, Baek JS. Biodegradable nanoparticles-loaded plga microcapsule for the enhanced encapsulation efficiency and controlled release of hydrophilic drug. Int J Mol Sci. 2021;22(6):2792. doi: https://doi.org/10.3390/IJMS22062792
24. Ravi S, Peh K, Darwis Y, Murthy B, Singh TR, Mallikarjun C. Development and characterization of polymeric microspheres for controlled release protein loaded drug delivery system. I J Pharm Sci. 2008;70(3):303. doi: https://doi.org/10.4103/IJPS.0250-474X.42978
25. Ramadan AEH, Elsayed MMA, Elsayed A, Fouad MA, Mohamed MS, Lee S, et al. Development and optimization of vildagliptin solid lipid nanoparticle-loaded ocuserts for controlled ocular delivery: a promising approach towards treating diabetic retinopathy. Int J Pharm X. 2024;7:100232. doi: https://doi.org/10.1016/J.IJPX.2024.100232
26. Azumah J, Smistad G, Hiorth M. Preparation of stable polymer-liposome complexes by a novel approach employing a one-pot method. Colloids Surf A Physicochem Eng Aspects. 2022;653:129924. doi: https://doi.org/10.1016/J.COLSURFA.2022.129924
27. Németh Z, Csóka I, Semnani Jazani R, Sipos B, Haspel H, Kozma G, et al. Quality by design-driven zeta potential optimisation study of liposomes with charge imparting membrane additives. Pharmaceutics. 2022;1798:1798. doi: https://doi.org/10.3390/PHARMACEUTICS.14091798
28. Sabry S, El Hakim Ramadan A, Abd Elghany M, Okda T, Hasan A. Formulation, characterization, and evaluation of the anti-tumor activity of nanosized galangin loaded niosomes on chemically induced hepatocellular carcinoma in rats. J Drug Deliv Sci Technol. 2021;61:102163. doi: https://doi.org/10.1016/J.JDDST.2020.102163
29. Huang J, Wigent RJ, Schwartz JB. Drug-polymer interaction and its significance on the physical stability of nifedipine amorphous dispersion in microparticles of an ammonio methacrylate copolymer and ethylcellulose binary blend. J Pharm Sci. 2008; 97(1):251–62. doi: https://doi.org/10.1002/JPS.21072
30. Zhu J, Liu B, Li L, Zeng Z, Zhao W, Wang G, et al. Simple and green fabrication of a superhydrophobic surface by one-step immersion for continuous oil/water separation. J Phys Chem A. 2016;120(28):5617–23. doi: http://dx.doi.org/10.12074/201705.00598
31. El-Emam GA, Girgis GNS, El-Sokkary MMA, El-Azeem Soliman OA, Abd El Gawad AEGH. Ocular inserts of voriconazole-loaded proniosomal gels: formulation, evaluation, and microbiological studies. Int J Nanomed. 2020;7825:7825–40. doi: https://doi.org/10.2147/IJN.S268208
32. Mohanty D, Zafar A, Jafar M, Upadhyay AK, Haque MA, Gupta JK, et al. Development, in-vitro characterization and preclinical evaluation of an esomeprazole-encapsulated proniosomal formulation for the enhancement of anti-ulcer activity. Molecules. 2022;27(9):2748. doi: http://dx.doi.org/10.3390/molecules27092748
33. Das U, Halder S, Kabir AKL, Rashid H, Rouf ASS. Development and in vitro evaluation of sustained-release matrix tablets of indapamide from Methocel® K15 MCR and K100 LVCR. Dhaka Uni J Pharm Sci. 2011;10(2):87–92. doi: https://doi.org/10.3329/DUJPS.10i2.11785
34. Vueba ML, Batista De Carvalho LAE, Veiga F, Sousa JJ, Pina ME. Influence of cellulose ether polymers on ketoprofen release from hydrophilic matrix tablets. Eu J Pharm Biopharm. 2004;58(1):51–9. doi: https://doi.org/10.1016/J.EJPB.2004.03.006
35. Elkomy MH, Ali AA, Eid HM. Chitosan on the surface of nanoparticles for enhanced drug delivery: a comprehensive review. J Control Release. 2022;351:923–40. doi: https://doi.org/10.1016/J.JCONREL.2022.10.005
36. Bozzuto G, Molinari A. Liposomes as nanomedical devices. Int J Nanomed. 2015;10:975–99. doi: https://doi.org/10.2147/IJN.S68861
37. Li X, Li Q, Zhao C. Zero-order controlled release of water-soluble drugs using a marker pen platform. ACS Omega. 2021;6(21):13774–8. doi: https://doi.org/10.1021/ACSOMEGA.1c01141
38. Baggi RB, Kilaru NB. Calculation of predominant drug release mechanism using the Peppas-Sahlin model, Part I (substitution method): a linear regression approach. Asian J Pharm Tech. 2016;6(4):223–30. doi: https://doi.org/10.5958/AJPT.2231-5713.2016.00033.7
39. Kim SS, Ro SW, Na DH. In vitro–in vivo correlation of microsphere formulations: recent advances and challenges. J Pharm Inv. 2024;54(1):37–49. doi: https://doi.org/10.1007/s40005-023-00655-6
Year
Month